Table 4 Sex and age-specific prevalence of premorbid Metabolic Syndrome based on WHO proposal
From: Screening premorbid metabolic syndrome in community pharmacies: a cross-sectional descriptive study
| Â | Prevalences of Pre-MetS | |||
|---|---|---|---|---|
| Â | Total (%) | Men (%) | Women (%) | p |
Age ranges: | Â | Â | Â | Â |
18-39 years | 8.7 (14/161) | 10.7 (8/75) | 7.0 (6/86) | 0.419 |
40-52 years | 17.9 (30/168) | 25.0 (21/84) | 10.7 (9/84) | 0.026 |
53-60 years | 28.1 (43/153) | 34.9 (22/63) | 23.3 (21/90) | 0.144 |
61-65 years | 35.3 (49/139) | 32.9 (25/76) | 38.1 (24/63) | 0.594 |
Total | 21.9 (136/621) | 25.5 (76/298) | 18.6 (60/323) | 0.041 |